News
Legal Commentary - Scrip Regulatory Affairs
The acceptance by the European court of justice of supplementary protection certificates having non-positive terms is welcome news for the innovative pharmaceutical industry, says Mike Snodin.
This article appeared in the January 2012 issue of Scrip Regulatory Affairs.
View attachment: Download File
